Vitamin E: Function and metabolism

FASEB Journal

Volumn 13, Issue 10, 1999, Pages 1145-1155

  Brigelius Flohé, Regina B F ^a   Traber, Maret G ^b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ASCORBIC ACID; BETA TOCOPHEROL; CARRIER PROTEIN; DELTA TOCOPHEROL; GAMMA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; PEROXYNITRITE; TERT BUTYL HYDROPEROXIDE;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CHRONIC DISEASE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; HEART INFARCTION; HUMAN; INFERTILITY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; VITAMIN METABOLISM;

ANIMALIA;

EID: 0033037413     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.10.1145     Document Type: Review

References (112)

1. IUPAC-IUB Joint Commission on Biochemical Nomenclature (1982) Nomenclature of tocopherols and related compounds. Recomendations 1981. Eur. J. Biochem. 123, 473-475
2. Sheppard, A. J., Pennington, J. A. T., and Weihrauch, J. L. (1993) Analysis and distribution of vitamin E in vegetable oils and foods. In Vitamin E in Health and Disease (Packer, L., and Fuchs, J., eds) pp. 9-31, Marcel Dekker, Inc., New York
3. 1-tocopherol and 5-methyltocol Br. J. Nutr. 15, 253-257
4. Weiser, H., Vecchi, M., and Schlachter, M. (1986) Stereoisomers of a-tocopheryl acetate. IV. USP units and α-tocopherol equivalents of all-rac-, 2-ambo-and RRR-α-tocopherol evaluated by simultaneous determination of resorption-gestation, myopathy and liver storage capacity in rats. Int. J. Vit. Nutr. Res. 56, 45-56
5. Weiser, H., Riss, G., and Kormann, A. W. (1996) Biodiscrimination of the eight alpha-tocopherol stereoisomers results in preferential accumulation of the four 2R forms in tissues and plasma of rats. J. Nutr. 126, 2539-2549
6. Brin, M. F., Pedley, T. A., Emerson, R. G., Lovelace, R. E., Gouras, P., MacKay, C, Kayden, H. J., Levy, J., and Baker, H. (1986) Electrophysiological features of abetalipoproteinemia: functional consequences of vitamin E deficiency. Neurology 36, 669-673
7. Sokol, R. J., Guggenheim, M., Iannaccone, S. T., Barkhaus, P. E., Miller, C., Silverman, A., Balistreri, W. F., and Heubi, J. E. (1985) Improved neurologic function after long-term correction of vitamin E deficiency in children with chronic cholestasis. N. Engl. J. Med. 313, 1580-1586
8. Sokol, R. J., Kayden, H. J., Bettis, D. B., Traber, M. G., Neville, H., Ringel, S., Wilson, W. B., and Stumpf, D. A. (1988) Isolated vitamin E deficiency in the absence of fat malabsorption - familial and sporadic cases: Characterization and investigation of causes J. Lab. Clin. Med. 111, 548-559
9. Kohlschütter, A., Hubner, C., Jansen, W., and Lindner, S. G. (1988) A treatable familial neuromyopathy with vitamin E deficiency, normal absorption, and evidence of increased consumption of vitamin E. J. Inher. Metab. Dis. 11, 149-152
10. Schuelke, M., Mayatepek, E., Inter, M., Becker, M., Pfeiffer, E., Speer, A., Hübner, C., and Finckh, B. (1999) Treatment of ataxia in isolated vitamin E deficiency caused by a-tocopherol transfer protein deficiency. J. Pediatr. 134, 240-244
11. Evans, H. M., and Bishop, K. S. (1922) On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 56, 650-651
12. Schwarz, K. (1965) Role of vitamin E, selenium, and related factors in experimental nutritional liver disease. Federation Proc. 24, 58-67
13. Tappel, A. L. (1962) Vitamin E as the biological lipid antioxidant. Vitam. Horm. 20, 493-510
14. Burton, G. W., and Ingold, K. U. (1986) Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc. Chem. Res. 19, 194-201
15. Esterbauer, H., Dieber-Rotheneder, M., Striegl, G., and Waeg, G. (1991) Role of vitamin E in preventing the oxidation of low density lipoprotein. Am. J. Clin. Nutr. 53, 314S-321S
16. Stampfer, M., Hennekens, C., Manson, J., Colditz, G., Rosner, B., and Willett, W. (1993) Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328, 1444-1449
17. Rimm, E. R., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A., and Willett, W. C. (1993) Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328, 1450-1456
18. Burton, G. W., Joyce, A., and Ingold, K. U. (1983) Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch. Biochem. Biophys. 221, 281-290
19. Ingold, K. U., Webb, A. C., Witter, D., Burton, G. W., Metcalfe, T. A., and Muller, D. P. R. (1987) Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency Arch. Biochem. Biophys. 259, 224-225
20. Packer, L. (1994) Vitamin E is nature's master antioxidant. Sci. Am. Sci. Med. 1, 54-63
21. Kamal-Eldin, A., and Appelqvist, L. A. (1996) The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31, 671-701
22. Ham, A. J., and Liebler, D. C. (1997) Antioxidant reactions of vitamin E in the perfused rat liver: product distribution and effect of dietary vitamin E supplementation. Arch. Biochem. Biophys. 339, 157-164
23. Stephens, N. G., Parsons, A., Schofield, P. M., Kelly, F., Cheeseman, K., and Mitchinson, M. J. (1996) Randomised controlled trial of vitamin E in patients with coronary disease - Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786
24. Motoyama, T., Kawano, H., Kugiyama, K., Hirashima, O., Ohgushi, M., Tsunoda, R., Moriyama, Y., Miyao, Y., Yoshimura, M., Ogawa, H., and Yasue, H. (1998) Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J. Am. Coll. Cardiol. 32, 1672-1679
25. Klein, T., Reutter, F., Schweer, H., Seyberth, H. W., and Nusing, R. M. (1997) Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases. J. Pharmacol. Exp. Ther. 282, 1658-1665
26. Moore, K., and Roberts, L. J. I. I. (1998) Measurement of lipid peroxidation. Free Rad. Res. 28, 659-671
27. Lynch, S. M., Morrow, J. D., Roberts, L. J. I.I., and Frei, B. (1994) Formation of noncyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest. 93, 998-1004
28. Awad, J. A., Morrow, J. D., Hill, K. E., Roberts, L. J. I.I., and Burk, R. F. (1994) Detection and localization of lipid peroxidation in selenium- and vitamin E-deficienl rats using F2-isoprostanes. J. Nutr. 124, 810-816
29. Pratico, D., Tangirala, R. K., Rader, D. J., Rokach, J., and FitzGerald, G. A. (1998) Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat. Med. 4, 1189-1192
30. Morrow, J. D., Minton, T. A., Badr, K. F., and Roberts, L. J., II (1994) Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. Biochim. Biophys. Acta 1210, 244-248
31. Reilly, M., Delanty, N., Lawson, J. A., and FitzGerald, G. A. (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94, 19-25
32. Delanty, N., Reilly, M., Pratico, D., FitzGerald, D. J., Lawson, J. A., and FitzGerald, G. A. (1996) 8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br. J. Clin. Pharmacol. 42, 15-19
33. Davi, G., Alessandrini, P., Mezetti, A., Minotti, G., Bucciarelli, T., Costantini, F., Cipollone, F., Bon, G. B., Ciabattoni, G., and Patrono, C. (1997) In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arierioscler. Thromb. Vase. Biol. 17, 3230-3235
34. Bowry, V. W., Ingold, K. U., and Stocker, R. (1992) Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem. J. 288, 341-344
35. Kontush, A., Finckh, B., Karten, B., Kohlschutter, A., and Beisiegel, U. (1996) Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein. J. Lipid Res. 37, 1436-1448
36. Upston, J. M., Terentis, A. C., and Stocker, R. (1999) Tocopherol-mediated peroxidation (TMP) of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J. 13 In press
37. Cooney, R. W., France, A. A., Harwood, P. J., Hatch-Pigott, V., Custer, L. J., and Mordan, L. J. (1993) γ-Tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proc. Natl. Acad, Sci. USA 90, 1771-1775
38. Cooney, R. V., Harwood, P. J., Franke, A. A., Narala, K., Sundstrom, A. K., Berggren, P. O., and Mordan, L. J. (1995) Products of gamma-tocopherol reaction with NO2 and their formation in rat insulinoma (RINm5F) cells. Free Rad. Biol. Med, 19, 259-269
39. x and complements α-tocopherol: physiological implications. Proc. Natl. Acad. Sci. USA 94, 3217-3222
40. Hoglen, N. C., Waller, S. C., Sipes, I. G., and Liebler, D. C. (1997) Reactions of peroxynitrite with γ-tocopherol. Chem. Res. Toxicol. 10, 401-407
41. Laplante, P., Vanasse, M., Michaud, J., Geoffroy, G., and Brochu, P. (1984) A progressive neurological syndrome associated with an isolated vitamin E deficiency. Can. J. Neurol. Sci. 11, 561-564
42. Krendel, D. A., Gilchrest, J. M., Johnson, A. O., and Bossen, E. H. (1987) Isolated deficiency of vitamin E with progressive neurologic deterioration. Neurology 37, 538-540
43. Stumpf, D. A., Sokol, R., Bettis, D., Neville, H., Ringel, S., Angelini, C., and Bell, R. (1987) Friedreich's disease: V. Variant form with vitamin E deficiency and normal fat absorption. Neurology 37, 68-74
44. Larnaout, A., Belal, S., Zouari, M., Fki, M., Ben Hamida, C., Goebel, H. H., Ben Hamida, M., and Hentati, F. (1997) Friedreich's ataxia with isolated vitamin E deficiency: a neuropathological study of a Tunisian patient. Acta Neuropathol. (Berlin) 93, 633-637
45. Burck, U., Goebel, H. H., Kuhlendahl, H. D., Meier, C., and Goebel, K. M. (1981) Neuromyopathy and vitamin E deficiency in man. Neuropediatrics 12, 267-278
46. Traber, M. G., Sokol, R. J., Ringel, S. P., Neville, H. E., Thellman, C. A., and Kayden, H. J. (1987) Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy N. Engl. J. Med. 317, 262-265
47. Kayden, H. J., and Silber, R. (1965) The role of vitamin E deficiency in the abnormal autohemolysis of acanthocytosis. Trans. Assoc. Am. Phys. 78, 334-341
48. Losowsky, M. S., and Leonard, P. J. (1967) Evidence of vitamin E deficiency in patients with malabsorption or alcoholism and the effects of therapy. Gut 8, 539-543
49. Farrell, P., Bien, J., Fratantoni, J., Wood, R., and Di Sant'Agnese, P, (1977) The occurrence and effects of human vitamin E deficiency. J. Clin. Invest. 60, 233-241
50. Simon, E., Paul, J. L., Atger, V., Simon, A., and Moatti, N. (1998) Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men. Atherosclerosis 138, 375-381
51. Traber, M. G., and Sies, H. (1996) Vitamin E in humans: demand and delivery Annu. Rev. Nutr. 16, 321-347
52. Ouahchi, K., Arita, M., Kayden, H., Hentati, F., Ben Hamida, M., Sokol, R., Arai, H., Inoue, K., Mandel, J.-L., and Koenig, M. (1995) Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nat. Genet. 9, 141-145
53. Gotoda, T., Arita, M., Arai, H., Inoue, K., Yokota, T., Fukuo, Y., Yazaki, Y., and Yamada, N. (1995) Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alphatocopherol-transfer protein. N. Engl. J. Med. 333, 1313-1318
54. Muller, D. P., Lloyd, J. K., and Wolff, O. H. (1985) The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption. J. Inherit. Metab. Dis. 8, 88-92
55. Azzi, A., Aratri, E., Boscoboinik, D., Clement, S., Ozer, N, K., Ricciarelli, R., and Spycher, S. (1998) Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation. Biofactors 7, 3-14
56. Boscoboinik, D., Szewczyk, A., Hensey, C., and Azzi, A. (1991) Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266, 6188-6194
57. Boscoboinik, D., Szewczyk, A., and Azzi, A. (1991) α-Tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 286, 264-269
58. Ricciarelli, R., Tasinato, A., Clement, S., Ozer, N. K., Boscoboinik, D., and Azzi, A. (1998) α-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 334, 243-249
59. Freedman, J. E., Farhat, J. H., Loscalzo, J., and Keaney, J. F. J. (1996) alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94, 2434-2440
60. Koya, D., Lee, I. K., Ishii, H., Kanoh, H., and King, G. L. (1997) Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol. 8, 426-435
61. Koya, D., Haneda, M., Kikkawa, R., and King, G. L. (1998) d-alpha-tocopherol treatment prevents glomerular dysfunctions in diabetic rats through inhibition of protein kinase C-diacylglycerol pathway. Biofactors 7, 69-76
62. Devaraj, S., Li, D., and Jialal, I. (1996) The effects of alphatocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J. Clin. Invest. 98, 756-763
63. Tran, K. T., Proulx, P., and Chan, A. C. (1994) Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity. Biochim. Biophys. Acta 1212, 193-202
64. Kunisaki, M., Bursell, S. E., Umeda, F., Nawata, H., and King, G. L. (1994) Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43, 1372-1377
65. Cachia, O., Benna, J. E., Pedruzzi, E., Descomps, B., Gougerot-Pocidalo, M. A., and Leger, C. L. (1998) α-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. J. Biol. Chem. 273, 32801-32805
66. Chan, A. C. (1998) Vitamin E and atherosclerosis. J. Nutr. 128, 1593-1596
67. Cominacini, L., Garbin, U., Pasini, A. F., Davoli, A., Campagnola, M., Contessi, G. B., Pastorino, A. M., and Lo Cascio, V. (1997) Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Rad. Biol. Med. 22, 117-127
68. Tran, K., Wong, J. T., Lee, E., Chan, A. C., and Choy, P. C. (1996) Vitamin E potentiates arachidonate release and phospholipase A2 activity in rat heart myoblastic cells. Biochem. J. 319, 385-391
69. Chan, A. C., Wagner, M., Kennedy, C, Mroske, C., Proulx, P., Laneuville, O., Tran, K., and Choy, P. C. (1998) Vitamin E up-regulates phospholipase A2, arachidonic acid release and cyclooxygenase in endothelial cells. Akt. Ernahr.-Med. 23, 1-8
70. Chan, A. C., and Leith, M. K. (1981) Decreased prostacyclin synthesis in vitamin E-deficient rabbit aorta. Am. J. Clin. Nutr. 34, 2341-2347
71. Gilbert, V. A., Zebrowski, E. J., and Chan, A. C. (1983) Differential effects of megavitamin E on prostacyclin and thromboxane synthesis in streptozotocin-induced diabetic rats. Horm. Metabol. Res. 15, 320-325
72. Szczeklik, A., Gryglewski, R. J., Domagala, B., Dworski, R., and Basista, M. (1985) Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb. Haemostasis 54, 425-430
73. Pyke, D. D., and Chan, A. C. (1990) Effects of vitamin E on prostacyclin release and lipid composition of the ischemic rat heart. Arch. Biochem. Biophys. 277, 429-433
74. Tran, K., and Chan, A. (1990) R, R, R-alpha tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for structural specificity of the tocopherol molecule. Biochim. Biophys. Acta 1043, 189-197
75. Burton, G. W., Cheeseman, K. H., Doha, T., Ingold, K. U., and Slater, T. F. (1983) Vitamin E as an antioxidant in vitro and in vivo. Ciba Found. Symp. 101, 4-18
76. Ursini, F., Maiorino, M., Valente, M., Ferri, L., and Gregolin, C. (1982) Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim. Biophys. Acta 710, 197-211
77. Maiorino, M., Coassin, M., Roveri, A., and Ursini, F. (1989) Microsomal lipid peroxidation: effect of vitamin E and its functional interaction with phospholipid hydroperoxide glutathione peroxidase. Lipids 24, 721-726
78. Tramer, F., Rocco, F., Micali, F., Sandri, G., and Panfili, E. (1998) Antioxidant systems in rat epididymal spermatozoa. Biol. Reprod. 59, 753-758
79. Wu, S. H., Oldfield, J. E., Whanger, P. D., and Weswig, P. H. (1973) Effect of selenium, vitamin E, and antioxidants on testicular function in rats. Biol. Reprod. 8, 625-629
80. Maiorino, M., Wissing, J. B., Brigelius-Flohé, R., Calabrese, F., Roveri, A., Steinert, P., Ursini, F., and Flohe, L. (1998) Testosterone mediates expression of the selenoprotein PHGPx by induction of spermatogenesis and not by direct transcriptional gene activation. FASEB J. 12, 1359-1370
81. Maiorino, M., Flohé, L., Roveri, A., Steinert, P., Wissing, J., and Ursini, F. (1999) BioFactors In press
82. Weiser, H., and Vecchi, M. (1981) Stereoisomers of α-tocopheryl acetate. Characterization of the samples by physico-chemical methods and determination of biological activities in the rat resorption-gestation test. Int. J. Vit. Nutr. Res. 51, 100-113
83. Weiser, H., and Vecchi, M. (1982) Stereoisomers of α-tocopheryl acetate. II. Biopotencies of all eight Stereoisomers, individually or in mixtures, as determined by rat resorption-gestation tests. Int. J. Vit. Nutr. Res. 52, 351-370
84. Kiyose, C., Muramatsu, R., Fujiyama-Fujiwara, Y., Ueda, T., and Igarashi, O, (1995) Biodiscrimination of alpha-tocopherol Stereoisomers during intestinal absorption. Lipids 30, 1015-1018
85. Burton, G. W., Ingold, K. U., Foster, D. O., Cheng, S. C., Webb, A., Hughes, L., and Lusztyk, E. (1988) Comparison of free a-tocopherol and α-tocopheryl acetate as sources of vitamin E in rats and humans. Lipids 23, 834-840
86. Drevon, C. A. (1991) Absorption, transport and metabolism of vitamin E. Free Rad. Res. Commun. 14, 229-246
87. Hosomi, A., Arita, M., Sato, Y., Kiyose, C., Ueda, T., Igarashi, O., Arai, H., and Inoue, K. (1997) Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409, 105-108
88. Ingold, K. U., Burton, G. W., Foster, D. O., Hughes, L., Lindsay, D. A., and Webb, A. (1987) Biokinetics of and discrimination between dietary RRR-and SRRα-tocopherols in the male rat. Lipids 22, 163-172
89. Burton, G. W., Traber, M. G., Acuff, R. V., Walters, D. N., Kayden, H., Hughes, L., and Ingold, K. (1998) Human plasma and tissue α-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am. J. Clin. Nutr. 67, 669-684
90. Kiyose, C., Muramatsu, R., Kameyama, Y., Ueda, T., and Igarashi, O. (1997) Biodiscrimination of alpha-tocopherol Stereoisomers in humans after oral administration. Am. J. Clin. Nutr. 65, 785-789
91. Schultz, M., Leist, M., Petrzika, M., Gassmann, B., and Brigelius-Flohé, R. (1995) Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2′-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply? Am. J. Clin. Nutr. 62 (Suppl.) 1527S-1534S
92. Jialal, I., Fuller, C. J., and Huet, B, A. (1995) The effect of α-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler. Thromb. Vasc. Biol. 15, 190-198
93. Dimitrov, N. V., Meyer, C., Gilliland, D., Ruppenthal, M., Chenoweth, W., and Malone, W. (1991) Plasma tocopherol concentrations in response to supplemental vitamin E. Am. J. Clin. Nutr. 53, 723-729
94. Traber, M. G., Rader, D., Acuff, R., Ramakrishnan, S., Brewer, H. B., and Kayden, H. J. (1998) Vitamin E dose response studies in humans using deuterated RRR-α-tocopherol. Am. J. Clin. Nutr. 68, 847-853
95. Traber, M. G., Ramakrishnan, R., and Kayden, H. J. (1994) Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-α-tocopherol. Proc. Natl. Acad. Sci. USA 91, 10005-10008
96. Liebler, D. C. (1993) The role of metabolism in the antioxidant function of vitamin E. Crit. Rev. Toxicol. 23, 147-169
97. Hayashi, T., Kanetoshi, A., Nakamura, M., Tamura, M., and Shirahama, H. (1992) Reduction of alpha-tocopherolquinone to alpha-tocopherolhydroquinone in rat hepatocytes. Biochem. Pharmacol. 44, 489-493
98. Liebler, D. C., Burr, J. A., Philips, L., and Ham, A. J. (1996) Gas chromatography-mass spectrometry analysis of vitamin E and its oxidation products. Anal. Biochem. 236, 27-34
99. Simon, E. J., Gross, C. S., and Milhorat, A. T. (1956) The metabolism of vitamin E. I. The absorption and excretion of d-α-tocopheryl-5-methyl-C14-succinate. J. Biol. Chem. 221, 797-805
100. Simon, E. J., Eisengart, A., Sundheim, L., and Milhorat, A. T. (1956) The metabolism of vitamin E. II. Purification and characterization of urinary metabolites of α-tocopherol. J. Biol. Chem. 221, 807-817
101. Schultz, M., Leist, M., Elsner, A., and Brigelius-Flohé, R. (1997) α-Carboxyethyl-6-hydroxychroman as an urinary metabolite of vitamin E. Methods Enzymol. 282, 297-310
102. Traber, M. G., Elsner, A., and Brigelius-Flohé, R. (1998) Synthetic as compared with natural vitamin E is preferentially excreted as α-CEHC in human urine; studies using deuterated α-tocopheryl acetates. FEBS Lett. 437, 145-148
103. Traber, M. G., Rader, D., Acuff, R., Brewer, H. B., and Kayden, H. J. (1994) Discrimination between RRR-and all rac-α-locopherols labeled with deuterium by patients with abetalipoproteinemia. Atherosclerosis 108, 27-37
104. Acuff, R. V., Thedford, S. S., Hidiroglou, N. N., Papas, A. M., and Odom, T. A. J. (1994) Relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate in humans: studies using deuterated compounds. Am. J. Clin. Nutr. 60, 397-402
105. Acuff, R. V., Dunworth, R. G., Webb, L. W., and Lane, J. R. (1998) Transport of deuterium-labeled tocopherols during pregnancy. Am. J. Clin. Nutr. 67, 459-464
106. Handelman, G. J., Machlin, L. J., Fitch, K., Weiter, J. J., and Dratz, E. A. (1985) Oral α-tocopherol supplements decrease plasma γ-tocopherol levels in humans. J. Nutr. 115, 807-813
107. Baker, H., Handelman, G. J., Short, S., Machlin, L. J., Bhagavan, H. N., Dratz, E. A., and Frank, O. (1986) Comparison of plasma α- and γ-tocopherol levels following chronic oral administration of either all-rac-α-tocopheryl acetate or RRR-α-tocopheryl acetate in normal adult male subjects. Am. J. Clin. Nutr. 43, 382-387
108. Wechter, W. J., Kantoci, D., Murray, E. D. J., D'Amico, D. C., Jung, M. E., and Wang, W.-H. (1996) A new endogenous natriuretic factor: LLU-alpha. Proc. Natl. Acad. Sci. USA 93, 6002-6007
109. Swanson, J. E., Ben, R., Burton, G. W., and Parker, R. S. (1998) Urinary excretion of 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxychroman (γ-CEHC) represents a major pathway of elimination of γ-tocopherol in humans. FASEB J. 12, A658 (abstr.)
110. Kantoci, D., Wechter, W. J., Murray, E. D. J., Dewind, S. A., Borchardt, D., and Khan, S. I. (1997) Endogenous natriuretic factors 6: the stereochemistry of a natriuretic gamma-tocopherol metabolite LLU-alpha. J. Pharmacol. Exp. Ther. 282, 648-656
111. Chiku, S., Hamamura, K., and Nakamura, T. (1984) Novel urinary metabolite of δ-tocopherol in rats. J. Lipid Res. 25, 40-48
112. Schönfeld, A., Schultz, M., Petrzika, M., and Gassmann, B. (1993) A novel metabolite of RRR-α-tocopherol in human urine. Die Nahrung. 37, 498-500